Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.

[1]  C. Malmendier,et al.  Kinetics of a heterogeneous population of particles in low density lipoprotein apolipoprotein B. , 1989, Atherosclerosis.

[2]  L. de Roy,et al.  Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. , 1989, Atherosclerosis.

[3]  S. Grundy,et al.  Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B. , 1988, Atherosclerosis.

[4]  J. Hoeg,et al.  3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. , 1987, JAMA.

[5]  R. Lees,et al.  Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. , 1987, Annals of internal medicine.

[6]  F. Cantraine,et al.  Comparison of different sandwich enzyme immunoassays for the quantitation of human apolipoproteins A-I and A-II. , 1987, Journal of immunological methods.

[7]  S. Grundy,et al.  In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. , 1986, The Journal of clinical investigation.

[8]  K. Bailey,et al.  Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia. , 1986, The American journal of cardiology.

[9]  S. Grundy,et al.  Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia. , 1985, Journal of lipid research.

[10]  D. Illingworth,et al.  Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia. , 1984, The Journal of clinical investigation.

[11]  Y. Chao,et al.  Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers. , 1982, The Journal of clinical investigation.

[12]  C. Packard,et al.  Receptor-independent catabolism of low density lipoprotein. Involvement of the reticuloendothelial system. , 1982, The Journal of biological chemistry.

[13]  C. Packard,et al.  Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.

[14]  M. Brown,et al.  Atherosclerosis: the low-density lipoprotein receptor hypothesis. , 1977, Metabolism: clinical and experimental.

[15]  R. Mahley,et al.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.

[16]  C. Malmendier,et al.  Metabolism of apolipoprotein C-III in normolipemic human subjects. , 1988, Atherosclerosis.

[17]  S. Grundy,et al.  Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. , 1983, Transactions of the Association of American Physicians.